TreeWAS – Variant ID: rs2286885

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H40.9 Glaucoma, unspecified	0.000	0.142	0.858
H40 Glaucoma	0.000	0.157	0.843
H40.1 Primary open-angle glaucoma	0.000	0.158	0.842
H40.5 Glaucoma secondary to other eye disorders	0.000	0.197	0.803
H40.3 Glaucoma secondary to eye trauma	0.000	0.372	0.628
H40.4 Glaucoma secondary to eye inflammation	0.000	0.373	0.627
H40.6 Glaucoma secondary to drugs	0.000	0.396	0.604
H40.8 Other glaucoma	0.000	0.587	0.412
H40-H42 Glaucoma	0.000	0.648	0.352
H40.2 Primary angle-closure glaucoma	0.000	0.730	0.270
H42 Glaucoma in diseases classified elsewhere	0.000	0.747	0.253
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.819	0.181
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.819	0.181
H40.0 Glaucoma suspect	0.000	0.857	0.143
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.895	0.105
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.060	0.940	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.051	0.949	0.000
C82.3 Follicular lymphoma grade IIIa	0.044	0.956	0.000
C82.0 Small cleaved cell, follicular	0.043	0.957	0.000
C82.2 Large cell, follicular	0.043	0.957	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.043	0.957	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.038	0.962	0.000
C82.6 Cutaneous follicle centre lymphoma	0.037	0.963	0.000
C82.5 Diffuse follicle centre lymphoma	0.037	0.963	0.000
C82.4 Follicular lymphoma grade IIIb	0.035	0.965	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.973	0.027
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.973	0.027
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.978	0.022
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.979	0.021
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.979	0.021
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.980	0.020
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.982	0.018
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.984	0.016
M65.9 Synovitis and tenosynovitis, unspecified	0.000	0.984	0.016
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.984	0.016
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.000	0.986	0.014
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.987	0.013
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.000	0.987	0.013
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.000	0.988	0.012
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.012	0.988	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.012	0.988	0.000
Y45.5 4-Aminophenol derivatives	0.012	0.988	0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.000	0.988	0.012
Y45.1 Salicylates	0.011	0.989	0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.989	0.011
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.990	0.010
Y45.2 Propionic acid derivatives	0.010	0.990	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.000	0.990	0.010
H66.3 Other chronic suppurative otitis media	0.009	0.991	0.000
Y45.4 Antirheumatics	0.009	0.991	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.992	0.008
Y45.0 Opioids and related analgesics	0.008	0.992	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.008	0.992	0.000
Y45.8 Other analgesics and antipyretics	0.008	0.992	0.000
Z74.0 Reduced mobility	0.008	0.992	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.007	0.993	0.000
O97 Death from sequelae of direct obstetric causes	0.000	0.993	0.007
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.000	0.993	0.007
O95 Obstetric death of unspecified cause	0.000	0.993	0.007
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.000	0.993	0.007
Y51 Drugs primarily affecting the autonomic nervous system	0.007	0.993	0.000
M65 Synovitis and tenosynovitis	0.000	0.993	0.007
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.007	0.993	0.000
T78.4 Allergy, unspecified	0.007	0.993	0.000
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.993	0.007
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.007	0.993	0.000
Z74.2 Need for assistance at home and no other household member able to render care	0.007	0.993	0.000
G93.3 Postviral fatigue syndrome	0.007	0.993	0.000
Z74 Problems related to care-provider dependency	0.007	0.993	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.006	0.994	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
A49.8 Other bacterial infections of unspecified site	0.006	0.994	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.006	0.994	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.006	0.994	0.000
T78 Adverse effects, not elsewhere classified	0.006	0.994	0.000
M65.1 Other infective (teno)synovitis	0.000	0.994	0.006
S80.8 Other superficial injuries of lower leg	0.006	0.994	0.000
M65.8 Other synovitis and tenosynovitis	0.000	0.994	0.006
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
Y57 Other and unspecified drugs and medicaments	0.006	0.994	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.006	0.994	0.000
O96.9 Death from unspecified obstetric cause	0.000	0.994	0.005
O96.1 Death from indirect obstetric cause	0.000	0.994	0.005
O96.0 Death from direct obstetric cause	0.000	0.994	0.005
O97.9 Death from sequelae of obstetric cause, unspecified	0.000	0.994	0.005
O97.1 Death from sequelae of indirect obstetric cause	0.000	0.994	0.005
O97.0 Death from sequelae of direct obstetric cause	0.000	0.994	0.005
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.006	0.994	0.000
Y52 Agents primarily affecting the cardiovascular system	0.006	0.994	0.000
Y59 Other and unspecified vaccines and biological substances	0.006	0.994	0.000
X10.0 Home	0.006	0.994	0.000
M65.2 Calcific tendinitis	0.000	0.994	0.005
T78.0 Anaphylactic shock due to adverse food reaction	0.005	0.995	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
Y51.0 Anticholinesterase agents	0.005	0.995	0.000
M65.0 Abscess of tendon sheath	0.000	0.995	0.005
Y58 Bacterial vaccines	0.005	0.995	0.000
T78.3 Angioneurotic oedema	0.005	0.995	0.000
Z74.8 Other problems related to care-provider dependency	0.005	0.995	0.000
M65.81 Other synovitis and tenosynovitis (Shoulder region)	0.000	0.995	0.005
Y57.5 X-ray contrast media	0.005	0.995	0.000
M65.14 Other infective (teno)synovitis (Hand)	0.000	0.995	0.005
Z74.1 Need for assistance with personal care	0.005	0.995	0.000
T78.9 Adverse effect, unspecified	0.005	0.995	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.005	0.995	0.000
Y57.9 Drug or medicament, unspecified	0.005	0.995	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
H66.4 Suppurative otitis media, unspecified	0.005	0.995	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.995	0.000
Y59.3 Immunoglobulin	0.005	0.995	0.000
H66 Suppurative and unspecified otitis media	0.005	0.995	0.000
K27 Peptic ulcer, site unspecified	0.005	0.995	0.000
Z74.9 Problem related to care-provider dependency, unspecified	0.005	0.995	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.005	0.995	0.000
Z74.3 Need for continuous supervision	0.005	0.995	0.000
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T78.2 Anaphylactic shock, unspecified	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.995	0.000
Y46.6 Other and unspecified antiepileptics	0.005	0.995	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.005	0.995	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
Y53.2 Stimulant laxatives	0.005	0.995	0.000
Y58.0 BCG vaccine	0.005	0.995	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.005	0.995	0.000
K27.3 Acute without haemorrhage or perforation	0.005	0.995	0.000
M65.4 Radial styloid tenosynovitis [de Quervain]	0.000	0.995	0.005
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.005	0.995	0.000
M65.19 Other infective (teno)synovitis (Site unspecified)	0.000	0.995	0.004
M65.18 Other infective (teno)synovitis (Other)	0.000	0.995	0.004
M65.17 Other infective (teno)synovitis (Ankle and foot)	0.000	0.995	0.004
M65.16 Other infective (teno)synovitis (Lower leg)	0.000	0.995	0.004
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)	0.000	0.995	0.004
M65.13 Other infective (teno)synovitis (Forearm)	0.000	0.995	0.004
M65.12 Other infective (teno)synovitis (Upper arm)	0.000	0.995	0.004
M65.11 Other infective (teno)synovitis (Shoulder region)	0.000	0.995	0.004
M65.10 Other infective (teno)synovitis (Multiple sites)	0.000	0.995	0.004
Y52.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.004
M65.86 Other synovitis and tenosynovitis (Lower leg)	0.000	0.995	0.004
Y52.7 Peripheral vasodilators	0.004	0.995	0.000
M65.89 Other synovitis and tenosynovitis (Site unspecified)	0.000	0.995	0.004
M65.88 Other synovitis and tenosynovitis (Other)	0.000	0.995	0.004
M65.85 Other synovitis and tenosynovitis (Pelvic region and thigh)	0.000	0.995	0.004
M65.82 Other synovitis and tenosynovitis (Upper arm)	0.000	0.995	0.004
M65.80 Other synovitis and tenosynovitis (Multiple sites)	0.000	0.995	0.004
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.995	0.000
Y55.5 Anticommon cold drugs	0.004	0.995	0.000
Y55.4 Expectorants	0.004	0.995	0.000
Y55.3 Antitussives	0.004	0.995	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.995	0.000
Y55.0 Oxytocic drugs	0.004	0.995	0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.000	0.995	0.004
H66.1 Chronic tubotympanic suppurative otitis media	0.004	0.995	0.000
T78.8 Other adverse effects, not elsewhere classified	0.004	0.995	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.000	0.996	0.004
K27.7 Chronic without haemorrhage or perforation	0.004	0.996	0.000
Y57.7 Vitamins, not elsewhere classified	0.004	0.996	0.000
Y57.4 Pharmaceutical excipients	0.004	0.996	0.000
Y57.3 Alcohol deterrents	0.004	0.996	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.004	0.996	0.000
Y57.1 Lipotropic drugs	0.004	0.996	0.000
Y57.0 Appetite depressants [anorectics]	0.004	0.996	0.000
Z52.3 Bone marrow donor	0.000	0.996	0.004
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
H16.0 Corneal ulcer	0.000	0.996	0.004
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
M65.83 Other synovitis and tenosynovitis (Forearm)	0.000	0.996	0.004
Y53.6 Antidiarrhoeal drugs	0.004	0.996	0.000
M65.21 Calcific tendinitis (Shoulder region)	0.000	0.996	0.004
Y52.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.996	0.000
Y59.2 Protozoal vaccines	0.004	0.996	0.000
Y59.1 Rickettsial vaccines	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
X10 Contact with hot drinks, food, fats and cooking oils	0.004	0.996	0.000
M65.29 Calcific tendinitis (Site unspecified)	0.000	0.996	0.004
M65.28 Calcific tendinitis (Other)	0.000	0.996	0.004
M65.27 Calcific tendinitis (Ankle and foot)	0.000	0.996	0.004
M65.26 Calcific tendinitis (Lower leg)	0.000	0.996	0.004
M65.25 Calcific tendinitis (Pelvic region and thigh)	0.000	0.996	0.004
M65.24 Calcific tendinitis (Hand)	0.000	0.996	0.004
M65.23 Calcific tendinitis (Forearm)	0.000	0.996	0.004
M65.22 Calcific tendinitis (Upper arm)	0.000	0.996	0.004
M65.20 Calcific tendinitis (Multiple sites)	0.000	0.996	0.004
M65.87 Other synovitis and tenosynovitis (Ankle and foot)	0.000	0.996	0.004
M65.09 Abscess of tendon sheath (Site unspecified)	0.000	0.996	0.004
M65.08 Abscess of tendon sheath (Other)	0.000	0.996	0.004
M65.07 Abscess of tendon sheath (Ankle and foot)	0.000	0.996	0.004
M65.06 Abscess of tendon sheath (Lower leg)	0.000	0.996	0.004
M65.05 Abscess of tendon sheath (Pelvic region and thigh)	0.000	0.996	0.004
M65.03 Abscess of tendon sheath (Forearm)	0.000	0.996	0.004
M65.02 Abscess of tendon sheath (Upper arm)	0.000	0.996	0.004
M65.01 Abscess of tendon sheath (Shoulder region)	0.000	0.996	0.004
M65.00 Abscess of tendon sheath (Multiple sites)	0.000	0.996	0.004
Y58.9 Other and unspecified bacterial vaccines	0.004	0.996	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.004	0.996	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.004	0.996	0.000
Y58.5 Diphtheria vaccine	0.004	0.996	0.000
Y58.4 Tetanus vaccine	0.004	0.996	0.000
Y58.3 Plague vaccine	0.004	0.996	0.000
Y58.2 Cholera vaccine	0.004	0.996	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.004	0.996	0.000
M65.04 Abscess of tendon sheath (Hand)	0.000	0.996	0.004
Y54.5 Other diuretics	0.004	0.996	0.000
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
Y57.6 Other diagnostic agents	0.004	0.996	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y46.2 Hydantoin derivatives	0.004	0.996	0.000
K22.8 Other specified diseases of oesophagus	0.004	0.996	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
Y53.7 Emetics	0.004	0.996	0.000
Y53.5 Digestants	0.004	0.996	0.000
Y53.3 Saline and osmotic laxatives	0.004	0.996	0.000
Y53.0 Histamine H2-receptor antagonists	0.004	0.996	0.000
K27.6 Chronic or unspecified with both haemorrhage and perforation	0.004	0.996	0.000
K27.5 Chronic or unspecified with perforation	0.004	0.996	0.000
K27.4 Chronic or unspecified with haemorrhage	0.004	0.996	0.000
K27.2 Acute with both haemorrhage and perforation	0.004	0.996	0.000
K27.1 Acute with perforation	0.004	0.996	0.000
K27.0 Acute with haemorrhage	0.004	0.996	0.000
T00 Superficial injuries involving multiple body regions	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y54.7 Agents affecting calcification	0.004	0.996	0.000
H66.0 Acute suppurative otitis media	0.004	0.996	0.000
M84.03 Malunion of fracture (Forearm)	0.000	0.996	0.004
Y46.8 Antispasticity drugs	0.004	0.996	0.000
Y46.3 Deoxybarbiturates	0.004	0.996	0.000
Y46.1 Oxazolidinediones	0.004	0.996	0.000
Y46.0 Succinimides	0.004	0.996	0.000
O41.0 Oligohydramnios	0.004	0.996	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.004	0.996	0.000
S89.9 Unspecified injury of lower leg	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
T00.9 Multiple superficial injuries, unspecified	0.004	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
Y46.5 Valproic acid	0.004	0.996	0.000
Y57.8 Other drugs and medicaments	0.004	0.996	0.000
Y56.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T00.6 Superficial injuries involving multiple regions of upper limb(s) with lower limb(s)	0.004	0.996	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.004	0.996	0.000
S86.8 Injury of other muscles and tendons at lower leg level	0.004	0.996	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.996	0.000
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec	0.000	0.996	0.003
M65.48 Radial styloid tenosynovitis [de Quervain]-Other	0.000	0.996	0.003
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot	0.000	0.996	0.003
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg	0.000	0.996	0.003
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh	0.000	0.996	0.003
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm	0.000	0.996	0.003
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region	0.000	0.996	0.003
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)	0.000	0.996	0.003
I65.2 Occlusion and stenosis of carotid artery	0.000	0.996	0.004
Y56.9 Topical agent, unspecified	0.003	0.996	0.000
Y56.8 Other topical agents	0.003	0.996	0.000
Y56.7 Dental drugs, topically applied	0.003	0.996	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.996	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.996	0.000
Y56.2 Local astringents and local detergents	0.003	0.996	0.000
Y56.1 Antipruritics	0.003	0.996	0.000
T00.8 Superficial injuries involving other combinations of body regions	0.004	0.996	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.996	0.000
Y41.4 Anthelminthics	0.003	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.996	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.996	0.004
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
Y54.0 Mineralocorticoids	0.003	0.996	0.000
Y41.5 Antiviral drugs	0.003	0.996	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.996	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.004	0.996	0.000
K81.0 Acute cholecystitis	0.000	0.996	0.004
J93.1 Other spontaneous pneumothorax	0.000	0.997	0.003
X10.9 Unspecified place	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.997	0.003
G95.2 Cord compression, unspecified	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
T00.3 Superficial injuries involving multiple regions of lower limb(s)	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T00.2 Superficial injuries involving multiple regions of upper limb(s)	0.003	0.997	0.000
J93.9 Pneumothorax, unspecified	0.000	0.997	0.003
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.997	0.003
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
O04.9 Complete or unspecified, without complication	0.000	0.997	0.003
X10.8 Other specified place	0.003	0.997	0.000
X10.7 Farm	0.003	0.997	0.000
X10.6 Industrial and construction area	0.003	0.997	0.000
X10.5 Trade and service area	0.003	0.997	0.000
X10.4 Street and highway	0.003	0.997	0.000
X10.3 Sports and athletics area	0.003	0.997	0.000
X10.2 School, other institution and public administrative area	0.003	0.997	0.000
X10.1 Residential institution	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
M65.3 Trigger finger	0.000	0.997	0.003
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
K85.9 Acute pancreatitis, unspecified	0.003	0.997	0.000
W44.0 Home	0.003	0.997	0.000
X10-X19 Contact with heat and hot substances	0.003	0.997	0.000
C22.1 Intrahepatic bile duct carcinoma	0.000	0.997	0.003
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.000	0.997	0.003
T00.1 Superficial injuries involving thorax with abdomen, lower back and pelvis	0.003	0.997	0.000
T00.0 Superficial injuries involving head with neck	0.003	0.997	0.000
J93 Pneumothorax	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.003	0.997	0.000
K22.7 Barrett's oesophagus	0.003	0.997	0.000
T66-T78 Other and unspecified effects of external causes	0.003	0.997	0.000
K59.1 Functional diarrhoea	0.000	0.997	0.003
R45.1 Restlessness and agitation	0.000	0.997	0.003
W24.9 Unspecified place	0.003	0.997	0.000
J93.8 Other pneumothorax	0.000	0.997	0.003
T75 Effects of other external causes	0.003	0.997	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.997	0.003
X12 Contact with other hot fluids	0.003	0.997	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.002	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.002	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
W44 Foreign body entering into or through eye or natural orifice	0.003	0.997	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.003	0.997	0.000
W24.6 Industrial and construction area	0.003	0.997	0.000
M65.38 Trigger finger-Other	0.000	0.997	0.002
M65.37 Trigger finger-Ankle/foot	0.000	0.997	0.002
M65.36 Trigger finger-Lower leg	0.000	0.997	0.002
M65.35 Trigger finger-Pelvic/thigh	0.000	0.997	0.002
M65.33 Trigger finger-Forearm	0.000	0.997	0.002
M65.32 Trigger finger-Upper arm	0.000	0.997	0.002
M65.31 Trigger finger-Shldr region	0.000	0.997	0.002
M65.30 Trigger finger-Mult sites	0.000	0.997	0.002
C22.9 Liver, unspecified	0.000	0.997	0.003
X12.0 Home	0.003	0.997	0.000
M65.39 Trigger finger-Site unspec	0.000	0.997	0.002
Z52.0 Blood donor	0.000	0.997	0.003
S86.1 Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level	0.003	0.997	0.000
T75.4 Effects of electric current	0.003	0.997	0.000
H53.4 Visual field defects	0.000	0.997	0.003
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
Z52 Donors of organs and tissues	0.000	0.997	0.003
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.002	0.997	0.000
Y48.1 Parenteral anaesthetics	0.002	0.997	0.000
Y48.0 Inhaled anaesthetics	0.002	0.997	0.000
X16 Contact with hot heating appliances, radiators and pipes	0.002	0.997	0.000
D86.0 Sarcoidosis of lung	0.000	0.997	0.003
J93.0 Spontaneous tension pneumothorax	0.000	0.997	0.002
T75.1 Drowning and nonfatal submersion	0.002	0.997	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.997	0.003
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.003	0.997	0.000
S86 Injury of muscle and tendon at lower leg level	0.002	0.997	0.000
X18 Contact with other hot metals	0.002	0.997	0.000
X17 Contact with hot engines, machinery and tools	0.002	0.997	0.000
X15 Contact with hot household appliances	0.002	0.997	0.000
X14 Contact with hot air and gases	0.002	0.997	0.000
X13 Contact with steam and hot vapours	0.002	0.997	0.000
X11 Contact with hot tap-water	0.002	0.997	0.000
T68 Hypothermia	0.002	0.997	0.000
C22.0 Liver cell carcinoma	0.000	0.998	0.002
T31.0 Burns involving less than 10% of body surface	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.001
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
W21 Striking against or struck by sports equipment	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T74 Maltreatment syndromes	0.002	0.998	0.000
T73 Effects of other deprivation	0.002	0.998	0.000
T69 Other effects of reduced temperature	0.002	0.998	0.000
T67 Effects of heat and light	0.002	0.998	0.000
T66 Unspecified effects of radiation	0.002	0.998	0.000
W20-W49 Exposure to inanimate mechanical forces	0.002	0.998	0.000
W21.8 Other specified place	0.002	0.998	0.000
W44.9 Unspecified place	0.002	0.998	0.000
X19 Contact with other and unspecified heat and hot substances	0.002	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.002	0.998	0.000
T75.8 Other specified effects of external causes	0.002	0.998	0.000
T75.3 Motion sickness	0.002	0.998	0.000
T75.2 Effects of vibration	0.002	0.998	0.000
T75.0 Effects of lightning	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
O41 Other disorders of amniotic fluid and membranes	0.002	0.998	0.000
S89 Other and unspecified injuries of lower leg	0.002	0.998	0.000
W24.8 Other specified place	0.002	0.998	0.000
W24.7 Farm	0.002	0.998	0.000
W24.5 Trade and service area	0.002	0.998	0.000
W24.4 Street and highway	0.002	0.998	0.000
W24.3 Sports and athletics area	0.002	0.998	0.000
W24.2 School, other institution and public administrative area	0.002	0.998	0.000
W24.1 Residential institution	0.002	0.998	0.000
W24.0 Home	0.002	0.998	0.000
X12.9 Unspecified place	0.002	0.998	0.000
X12.6 Industrial and construction area	0.002	0.998	0.000
X12.8 Other specified place	0.002	0.998	0.000
X12.7 Farm	0.002	0.998	0.000
X12.5 Trade and service area	0.002	0.998	0.000
X12.4 Street and highway	0.002	0.998	0.000
X12.3 Sports and athletics area	0.002	0.998	0.000
X12.2 School, other institution and public administrative area	0.002	0.998	0.000
X12.1 Residential institution	0.002	0.998	0.000
Z57.2 Occupational exposure to dust	0.000	0.998	0.002
H16 Keratitis	0.000	0.998	0.002
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
H16.9 Keratitis, unspecified	0.000	0.998	0.002
W21.9 Unspecified place	0.002	0.998	0.000
W44.5 Trade and service area	0.002	0.998	0.000
W44.7 Farm	0.002	0.998	0.000
W44.6 Industrial and construction area	0.002	0.998	0.000
W44.4 Street and highway	0.002	0.998	0.000
W44.3 Sports and athletics area	0.002	0.998	0.000
W44.2 School, other institution and public administrative area	0.002	0.998	0.000
W44.1 Residential institution	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
T71 Asphyxiation	0.002	0.998	0.000
H33.5 Other retinal detachments	0.002	0.998	0.000
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.002	0.998	0.000
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.002	0.998	0.000
L92.0 Granuloma annulare	0.002	0.998	0.000
O41.1 Infection of amniotic sac and membranes	0.002	0.998	0.000
Z52.2 Bone donor	0.000	0.998	0.002
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Z81.8 Family history of other mental and behavioural disorders	0.002	0.998	0.000
O41.8 Other specified disorders of amniotic fluid and membranes	0.002	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Z52.9 Donor of unspecified organ or tissue	0.000	0.998	0.002
Z52.7 Heart donor	0.000	0.998	0.002
Z52.6 Liver donor	0.000	0.998	0.002
Z52.5 Cornea donor	0.000	0.998	0.002
Z52.1 Skin donor	0.000	0.998	0.002
W44.99 Foreign body entering into or through eye or natural orifice, Unspecified place , During unspecified activity	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.998	0.002
X16.0 Home	0.002	0.998	0.000
X23.9 Unspecified place	0.002	0.998	0.000
T70 Effects of air pressure and water pressure	0.002	0.998	0.000
W26 Contact with knife, sword or dagger	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
S86.3 Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level	0.002	0.998	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.002	0.998	0.000
X16.9 Unspecified place	0.002	0.998	0.000
X16.8 Other specified place	0.002	0.998	0.000
X16.7 Farm	0.002	0.998	0.000
X16.6 Industrial and construction area	0.002	0.998	0.000
X16.5 Trade and service area	0.002	0.998	0.000
X16.4 Street and highway	0.002	0.998	0.000
X16.3 Sports and athletics area	0.002	0.998	0.000
X16.2 School, other institution and public administrative area	0.002	0.998	0.000
X16.1 Residential institution	0.002	0.998	0.000
W22 Striking against or struck by other objects	0.002	0.998	0.000
C22.7 Other specified carcinomas of liver	0.000	0.998	0.002
C22.4 Other sarcomas of liver	0.000	0.998	0.002
C22.3 Angiosarcoma of liver	0.000	0.998	0.002
C22.2 Hepatoblastoma	0.000	0.998	0.002
K22.9 Disease of oesophagus, unspecified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations